Macro Briefing | 2 July 2020
Gold on track to reach new highs
"This Might Be The Craziest Thing I've Seen In My Stock Market Career"
Markets vaccinate ahead of Non-Farm Payrolls
Which drugs and therapies are proven to work, and which ones don't, for COVID-19?
Rehired Workers Get Axed As States Pause Or Reverse Reopening
June Payrolls Preview: It Could Go Either Way
Facebook Faces More Ad Boycotts, But This Analyst Expects Minimal Impact
The Chain Reaction Is Now In Process
Huge Political Disconnect Over The State Of The Economy
Hedge Fund Liquidations Soar To Highest Level Since 2015
Asia Stocks Rally, Europe and US Likely to Follow
Making health systems stronger while tackling the impacts of COVID-19
Goldman Sachs: There's an Opportunity Brewing in These 3 Stocks
Storm Warning
John Paulson Converts Hedge Fund Into Family Office
Reopening America: Three ways to preserve jobs
Macy’s Confirms Sales Plunge, Reveals $3.1B Impairment Charge
July Monthly
Why we need a Blue Recovery
3 High-Yield Dividend Stocks That Score a “Perfect 10”
US Manufacturing Survey Jumps By Record In June (In Contraction & Expansion)
Digital Financial Inclusion in the Times of COVID-19
US government buys most of world’s supply of COVID-19 drug remdesivir
Currency Markets Remain in Hibernation
NAIRU, And Other Will-O'-The-Wisps
Seven ways social distancing will change restaurants
Can we go back to pre-crisis oil prices?
Asian Equities Stage Rally, Europe and US Expected to Follow
COVID-19 and teletherapy may be changing how much you know about your therapist